Table 3

Univariate and multivariate analysis (Cox model) of overall survival

Univariate
Multivariate
HR95% CIPHR95% CIP
Response*   < .001   < .001 
    CR vs VGPR 0.15 0.08-0.28 < .001 0.25 0.11-0.55 .001 
    CR vs PR 0.08 0.04-0.16 < .001 0.16 0.06-0.39 < .001 
    CR vs SD 0.03 0.01-0.06 < .001 0.07 0.02-0.20 < .001 
    CR vs PD 0.01 0.005-0.03 < .001 0.03 0.009-0.11 < .001 
Age, y       
    > 75 vs ≤ 75 1.59 1.29-1.96 < .001 1.30 1.00-1.70 .053 
ISS   < .001   < .001 
    II vs I 1.73 1.24-2.43 .001 1.41 0.99-2.01 .056 
    III vs I 2.84 2.00-4.04 < .001 2.17 1.49-3.15 < .001 
Durie and Salmon stage       
    III vs II 1.38 1.10-1.73 .006 1.38 1.04-1.82 .024 
Therapy   < .001   .003 
    MPT vs MP 0.88 0.71-1.10 .263 1.00 0.76-1.31 .991 
    VMP vs MP 0.25 0.17-0.38 < .001 0.30 0.14-0.64 .002 
    VMPT-VT vs MP 0.23 0.15-0.36 < .001 0.50 0.26-0.95 .035 
Univariate
Multivariate
HR95% CIPHR95% CIP
Response*   < .001   < .001 
    CR vs VGPR 0.15 0.08-0.28 < .001 0.25 0.11-0.55 .001 
    CR vs PR 0.08 0.04-0.16 < .001 0.16 0.06-0.39 < .001 
    CR vs SD 0.03 0.01-0.06 < .001 0.07 0.02-0.20 < .001 
    CR vs PD 0.01 0.005-0.03 < .001 0.03 0.009-0.11 < .001 
Age, y       
    > 75 vs ≤ 75 1.59 1.29-1.96 < .001 1.30 1.00-1.70 .053 
ISS   < .001   < .001 
    II vs I 1.73 1.24-2.43 .001 1.41 0.99-2.01 .056 
    III vs I 2.84 2.00-4.04 < .001 2.17 1.49-3.15 < .001 
Durie and Salmon stage       
    III vs II 1.38 1.10-1.73 .006 1.38 1.04-1.82 .024 
Therapy   < .001   .003 
    MPT vs MP 0.88 0.71-1.10 .263 1.00 0.76-1.31 .991 
    VMP vs MP 0.25 0.17-0.38 < .001 0.30 0.14-0.64 .002 
    VMPT-VT vs MP 0.23 0.15-0.36 < .001 0.50 0.26-0.95 .035 

SD indicates stable disease; and PD, progressive disease.

*

Treated as a time-dependent variable.

or Create an Account

Close Modal
Close Modal